Fact CheckerSign in

NCT05866887Completed

Insomnia Prevention in Children With Acute Lymphoblastic Leukemia

Source: ClinicalTrials.gov · Last updated 6 Jun 2025

Brief summary (registry, in English)

The goal of this research study is to understand the acceptability and feasibility of the Sleep ALL Night intervention among children with Acute Lymphoblastic Leukemia (ALL) in hopes of improving the discussion of sleep disorders with clinical providers. The name of the intervention used in this research study is: Sleep ALL Night, which is a sleep intervention program comprised of an action plan tool and psychoeducational website.

Status (registry)
Completed
Study type
Interventional
Enrollment
25 (actual)
First submitted
10 May 2023
Start date
26 Sept 2023
Primary completion date
5 Jun 2024
Lead sponsor
Dana-Farber Cancer Institute
NCT number
NCT05866887

What you commit to

  • Study type: Interventional
  • Participants enrolled: 25
  • From 26 Sept 2023 to the primary completion date, 5 Jun 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Children with critical illness (defined as ICU admission)

Other

  • Primary team declines permission to approach.

Who the study is looking for

  • Patient in the Maintenance Phase of therapy on or as per DFCI 16-001 and has completed at least two cycles of maintenance therapy to allow adequate recovery from the more intensive Consolidation phase.
  • English or Spanish speaking child and primary caregiver (parent/guardian).
  • Child aged 4-12 years.

Age in the registry: 4 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dana-Farber Cancer Institute
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status
Boston Children's Hospital
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.